Evid Invest
Who owns AVTXWhat AVTX owns — n/a

Who owns Avalo Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of AVTX from SEC Form 13F filings across 148 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 148 institutions disclosed 71.6M shares of Avalo Therapeutics, Inc. worth $1.10B — about 130.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

148

13F holders

$1.10B

value, 2026 filers

130.1%

of shares outstanding (71.6M sh)

38

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AVTX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC5.3M$80.5M0.0%9.5%+2.9%
2BlackRock, Inc.5.0M$76.0M0.0%9%+13.6%
3FARALLON CAPITAL MANAGEMENT, L.L.C.4.0M$60.9M0.3%7.2%+59.1%
4Deep Track Capital, LP3.6M$55.3M0.9%6.6%0.0%
5Caligan Partners LP3.3M$50.1M3.1%5.9%+3.3%
6Affinity Asset Advisors, LLC3.2M$49.7M2.0%5.9%+11.9%
7TCG Crossover Management, LLC3.0M$46.3M1.3%5.5%0.0%
8STATE STREET CORP2.6M$39.3M0.0%4.7%-11.3%
9Avoro Capital Advisors LLC2.4M$36.5M0.4%4.3%+1.9%
10VANGUARD CAPITAL MANAGEMENT LLC2.3M$34.6M0.0%4.1%-0.4%
11Nantahala Capital Management, LLC2.1M$32.8M1.0%3.9%+15.0%
12PRICE T ROWE ASSOCIATES INC /MD/1.9M$29.4M0.0%3.5%+46.2%
13BANK OF AMERICA CORP /DE/1.8M$27.2M0.0%3.2%-7.2%
14Point72 Asset Management, L.P.1.6M$24.9M0.0%3%-31.9%
15BRAIDWELL LP1.6M$24.7M1.0%2.9%-1.2%
16ADAGE CAPITAL PARTNERS GP, L.L.C.1.6M$24.5M0.0%2.9%-7.5%
17Trails Edge Capital Partners, LP1.5M$23.0M3.3%2.7%+68.2%
18ALLIANCEBERNSTEIN L.P.1.4M$21.4M0.0%2.5%+10.8%
19GEODE CAPITAL MANAGEMENT, LLC1.3M$19.4M0.0%2.3%+14.3%
20AMERIPRISE FINANCIAL INC1.1M$16.5M0.0%2%+21.1%
21Commodore Capital LP1.0M$15.6M1.2%1.8%0.0%
22RA CAPITAL MANAGEMENT, L.P.1.0M$15.3M0.2%1.8%0.0%
23Parkman Healthcare Partners LLC929,432$14.2M1.3%1.7%+21.3%
24BVF INC/IL907,406$13.9M0.5%1.6%-56.3%
25Vestal Point Capital, LP800,000$12.3M0.3%1.5%+3.2%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.
EvidInvest Pro: unlimited filings data, $50/month